However, there was a dramatic shift in the subcellular localisation: nuclear MI-ER1α was detectable in 75% of normal breast samples and in 77% of hyperplasia, but in breast carcinoma, only 51% of DCIS, 25% of ILC and 4% of IDC contained nuclear staining. This evidence concerns the gene CCL27 and breast carcinoma.